On Tuesday, Shares of Quintiles IMS Holdings Inc (NYSE:Q), included 0.22% and shut at $80.20 inside the end purchasing and offering session. The last exchanging scope of the stock ranges amongst $79.65 and $80.55. QuintilesIMS (NYSE:Q) declared recently that it will lead a collaborative program involving founding partners Bristol-Myers Squibb, Eli Lilly and Company, Merck KGaA, Darmstadt, Germany and Pfizer, which aims to provide clearer and more proactive insight into how anti-cancer treatments are used in a real-world setting across key European markets.
Presently, there are major information gaps and inconsistencies in knowledge about the real-world use of oncology products across Europe. Additional information about how oncology products are actually used, for which types of patients, with what sequences and combinations of therapies, and in which indications, is particularly important to assist improve oncology patient care.
Treatment use information is typically based on historical data, thereby providing a view of the past, not a view of current practice. This new program is intended to provide more timely, consistent and comprehensive data resources that could be used to provide further insight for healthcare systems to make better informed decisions on patient care in the future. Importantly, substantial steps have been taken to obtain these insights while respecting individual privacy.
Shares of Depomed Inc (NASDAQ:DEPO), subtract -1.61% and shut at $20.14 inside the last exchanging session. The rest of the purchasing and offering scope of the stock levels among $18.27 and $20.69. The association’s commercial center capitalization is $1.24 Billion with the general uncommon loads of 61.58 million. Depomed, Inc. (DEPO) recently declared that it will take part in a fireside chat at the 28th Annual Piper Jaffray Healthcare Conference planned for 2:00 pm ET (11:00 am PT) on Tuesday, November 29, 2016 in New York, New York.
The fireside chat will be webcast live and may be accessed via the Shareholder Relations page of the Depomed website.